Nordic Bio-invest Group aps

CVR 42283681 · Private limited company (ApS) · Active · Low risk

Nordic Bio-invest Group aps is a Private limited company (ApS), founded on , based in Hørsholm. The company is registered in the industry ikke-finansielle holdingselskaber. Our model estimates a bankruptcy risk of 0.2% over the next 12 months, which is 0.1 times the average for Danish companies. 5 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 492k and a net result of DKK -1,600. CEO: Martin Schmidt Grunstrup Taarnhøj.

Bankruptcy risk for Nordic Bio-invest Group aps

0.2%
probability of bankruptcy within 12 months
Low risk

0.1 × the average (1.41%) · higher risk than 44% of active Danish companies

Lowest riskHighest risk

Increases the risk

Auditor's statementNo assurance · bankruptcy rate 13.2%1.5×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Audit opted outYes · bankruptcy rate 10.4%1.2×
Auditor registered in CVRNo · bankruptcy rate 10.4%1.2×
Loss for the yearYes · bankruptcy rate 10.3%1.2×

Reduces the risk

Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Time since new CEO5+ yrs · bankruptcy rate 3.8%0.43×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Registered owners4+ · bankruptcy rate 5.7%0.65×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×
Return on assets-20%–0% · bankruptcy rate 6.2%0.70×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
42283681
Status
Active
Company type
Private limited company (ApS)
Founded
(5 years)
Address
c/o Martin Taarnhøj, Breeltedal 6
2970 Hørsholm
Municipality
Hørsholm
Industry
Ikke-finansielle holdingselskaber (642120)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber
Share capital
DKK 500k
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 5
Missing annual reportNo
Negative equityNo
Equity ratio80.4%
Current ratio0%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address1
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Net profitDKK -1,600DKK -2,424
EquityDKK 492kDKK 494k
Total assetsDKK 612kDKK 614k
CashDKK 0–
Short-term debtDKK 120k–
Avg. employees0–

Latest annual report: Reporting class B · auditor's statement: No assurance.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 202536
1 Jan 2024 – 31 Dec 202459
1 Jan 2023 – 31 Dec 202318
1 Jan 2022 – 31 Dec 202262
6 Apr 2021 – 31 Dec 202155

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOMartin Schmidt Grunstrup TaarnhøjCurrent
Owner (25%)Inger SchmidtCurrent
Owner (25%)RASMUS BUSK HOLDING ApSCurrent
Owner (25%)DMS Holding ApSCurrent
Owner (25%)TypeLives ApSCurrent
FounderInger SchmidtCurrent
FounderRASMUS BUSK HOLDING ApSCurrent
FounderDMS Holding ApSCurrent
FounderTypeLives ApSCurrent

The CEOs' other companies

Martin Schmidt Grunstrup Taarnhøj – 3 other companies

Address history (1 moves)

c/o Martin Taarnhøj, Breeltedal 6, 2970 Hørsholm
Damgårdsvej 9, 3460 Birkerød

Other companies at the same address

Similar companies in Hørsholm

Questions and answers about Nordic Bio-invest Group aps

Has Nordic Bio-invest Group aps gone bankrupt?

No, Nordic Bio-invest Group aps is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Nordic Bio-invest Group aps?

Our model estimates a bankruptcy risk of 0.2% over the next 12 months (low risk), which is 0.1 times the average for Danish companies.

Who is the CEO of Nordic Bio-invest Group aps?

Martin Schmidt Grunstrup Taarnhøj is the CEO of Nordic Bio-invest Group aps.

When was Nordic Bio-invest Group aps founded?

Nordic Bio-invest Group aps was founded on 6 April 2021.

What is the equity of Nordic Bio-invest Group aps?

Equity was DKK 492k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.